Skip to main content

Table 2 Oncological and surgical outcome

From: A standardized suprapubic bottom-to-up approach in robotic right colectomy: technical and oncological advances for complete mesocolic excision (CME)

  bottom-to-up (BTU-group) medial-to-lateral (MLT-group) p-value
  n = 17 n = 7  
T-stage (%(n))
 1 11,8 (2) 14.3 (1) 0.153 (F)
 2 11,8 (2) 28,6 (2)
 3 70,6 (12) 28,6 (2)
 4 5,9 (1) 28,6 (2)
N-Stage (%(n))
 0 58,8 (10) 85,7 (6) 0.332 (F)
 1 29,4 (5) 0.0 (0)
 2 11,8 (2) 14,3 (1)
Tumor involved margins (%(n)) 0 (0) 0 (0) 1
Total no. retrieved lymph nodes
 mean ± SD 40.2 ± 17.1 16.3 ± 8.5 < 0.001 (W)
 median (range) 38 (14–86) 12 (9–30)
Cases with fewer than 12 LNs (%(n)) 0.0 (0) 28.6 (2) 0.045 (F)
No. of positive lymph nodes, median (range) 0 (0–15) 0 (0–5) 0.272 (W)
  n = 24 N = 7  
No. of conversions 0 (0) 0 (0) 1.000 (F)
Skin-to-skin OR-time (min; mean ± SD) 283.6 ± 87.9 287.5 ± 45.0 0.671 (W)
time to first flatus (d; mean ± SD) 1.4 ± 1.1 0.6 ± 1.0 0.074 (W)
ICU stay (d; median (range)) 0.0 (0–8) 0.0 (0–1) 0.534 (W)
Hospital stay (d; mean ± SD)) 10.7 ± 2.6 11.6 ± 3.7 0.721 (W)
Patients with complications (%(n)) 33.3 (8) 42.9 (3) 0.676 (F)
Patients with DinCla complications (%(n))
 DinCla I complications 29.2 (7) 28.6 (2) 0.633 (F)
 DinCla II complications 4.2 (1) 14.3 (1)
 DinCla III/IV complications 0.0 (0) 0.0 (0)
Postoperative mortality / DinCla V (%(n)) 0.0 (0) 0.0 (0) 1.000 (F)
Type of morbidity (%(n))
 Surgical site infection 8.3 (2) 0.0 (0) 1.000 (F)
 Ileus 0.0 (0) 0.0 (0) 1.000 (F)
 Anastomotic leakage 0.0 (0) 0.0 (0) 1.000 (F)
 anemia 4.4 (1) 14.3 (1) 0.406 (F)
 Pneumonia 12.5 (3) 0.0 (0) 1.000 (F)
 urinary tract infection 4.4 (1) 0.0 (0) 1.000 (F)
 lymphatic fistula 4.4 (1) 0.0 (0) 1.000 (F)
 incisional hernia 4.4 (1) 14.3 (1) 0.406 (F)
  1. DinCla – According to Dindo/Clavien classification of complications [17]. W Two-sample Wilcoxon rank-sum (Mann-Whitney) test, F Fisher’s exact test, SD Standard deviation, A ANOVA. P-values of < 0.05 were regarded to be significant